Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases.
Document Type
Journal Article
Publication Date
9-1-2017
Journal
Clinical Cancer Research : An Official Journal of the American Association for Cancer Research
Volume
23
Issue
17
DOI
10.1158/1078-0432.CCR-17-1043
APA Citation
Kotian, S., Zhang, L., Boufraqech, M., Gaskins, K., Gara, S., Quezado, M., Nilubol, N., & Kebebew, E. K. (2017). Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases.. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 23 (17). http://dx.doi.org/10.1158/1078-0432.CCR-17-1043
Peer Reviewed
1
